Previous 10 | Next 10 |
Thesis Update On March 19, Seeking Alpha published my long recommendation on Avantor ( AVTR ) , a misunderstood relative value play in the healthcare sector. From 3/18 closing prices, the stock is now up ~65% versus ~20% for the S&P 500 and 9% for Thermo Fisher Scientific ( TMO ), t...
RADNOR, Pa. , April 3, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life science and advanced technologies & applied materials industries, announced today that it will release its financia...
Investment Thesis Avantor ( AVTR ) is a misunderstood relative value play in the healthcare sector that now trades at a 50-60% discount (depending on which multiple) to its closest peer Thermo Fisher Scientific ( TMO ). It is down 54% from the 2/19 market peak versus 29% for the S&P 50...
This article was selected to be shared with PRO subscribers, who also got 7 days' exclusive access to Viceni Investing's original Top Idea on Avantor (AVTR). Viceni Investing is an individual investor and retired sell-side analyst rated top 10 by Institutional Investor magazine. F...
RADNOR, Pa. , March 23, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced Tommy Thomas has joined the Compan...
RADNOR, Pa. , March 18, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced a new recombinant Protein A affinity chro...
This article is part of a series that provides an ongoing analysis of the changes made to Ole Andreas Halvorsen’s 13F stock portfolio on a quarterly basis. It is based on Viking Global’s regulatory 13F Form filed on 02/13/2020. Please visit our Tracking Ole Andreas Halvorsen...
RADNOR, Pa. , Feb. 18, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that Michael Stubblefield , President...
This article is part of a series that provides an ongoing analysis of the changes made to Dan Loeb’s 13F stock portfolio on a quarterly basis. It is based on Third Point’s regulatory 13F Form filed on 02/13/2020. Please visit our Tracking Dan Loeb’s Third Point Portfoli...
Avantor, Inc. (AVTR) Q4 2019 Earnings Conference Call February 7, 2020 08:30 AM ET Company Participants Helen O'Donnell - Investor Relations Michael Stubblefield - President and Chief Executive Officer Tom Szlosek - Executive Vice President and Chief Financial Officer Conferen...
News, Short Squeeze, Breakout and More Instantly...
2024-07-29 07:15:06 ET Barclays analyst issues OVERWEIGHT recommendation for AVTR on July 29, 2024 05:42AM ET. The previous analyst recommendation was Overweight. AVTR was trading at $25.6 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...
Bogota Financial Corp. (BSBK) is expected to report for Q2 2024 Capital Product Partners L.P. (CPLP) is expected to report $0.17 for Q2 2024 Colgate-Palmolive Company (CL) is expected to report $0.87 for Q2 2024 ARCA biopharma Inc. (ABIO) is expected to report for Q2 2024 Barnes G...
Avantor® Reports Second Quarter 2024 Results PR Newswire Net sales of $1.70 billion , decrease of 2.4%; organic decline of 2.0% Net income of $93 million ; Adjusted EBITDA of $306 million Diluted GAAP EPS of $0.14 ; adjusted EPS of $0.25 Op...